142 related articles for article (PubMed ID: 21589878)
1. Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
Roescher N; Vosters JL; Yin H; Illei GG; Tak PP; Chiorini JA
PLoS One; 2011 May; 6(5):e19962. PubMed ID: 21589878
[TBL] [Abstract][Full Text] [Related]
2. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
3. Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation.
Roescher N; Vosters JL; Lai Z; Uede T; Tak PP; Chiorini JA
PLoS One; 2012; 7(12):e51375. PubMed ID: 23300544
[TBL] [Abstract][Full Text] [Related]
4. TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.
Vosters JL; Roescher N; Illei GG; Chiorini JA; Tak PP
Oral Dis; 2012 May; 18(4):365-74. PubMed ID: 22212434
[TBL] [Abstract][Full Text] [Related]
5. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.
Roescher N; Lodde BM; Vosters JL; Tak PP; Catalan MA; Illei GG; Chiorini JA
Oral Dis; 2012 Jan; 18(1):96-106. PubMed ID: 21914088
[TBL] [Abstract][Full Text] [Related]
7. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
9. Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome.
Vosters JL; Yin H; Roescher N; Kok MR; Tak PP; Chiorini JA
Arthritis Res Ther; 2009; 11(6):R189. PubMed ID: 20003451
[TBL] [Abstract][Full Text] [Related]
10. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.
Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U
J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic anti-inflammatory pathway in the non-obese diabetic mouse model.
Koopman FA; Vosters JL; Roescher N; Broekstra N; Tak PP; Vervoordeldonk MJ
Oral Dis; 2015 Oct; 21(7):858-65. PubMed ID: 26096224
[TBL] [Abstract][Full Text] [Related]
13. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
16. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
17. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of protein and gene expression in salivary glands of Sjogren's-like disease NOD mice treated by bone marrow soup.
Misuno K; Tran SD; Khalili S; Huang J; Liu Y; Hu S
PLoS One; 2014; 9(1):e87158. PubMed ID: 24489858
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.
Skarstein K; Wahren M; Zaura E; Hattori M; Jonsson R
Autoimmunity; 1995; 22(1):9-16. PubMed ID: 8882417
[TBL] [Abstract][Full Text] [Related]
20. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
